1. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
   Marzia Pennati et al, 2005, Molecular Cancer Therapeutics CrossRef
2. Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
   Roberto R. Rosato et al, 2005, Molecular Cancer Therapeutics CrossRef
3. Novel Targets for Lung Cancer Therapy: Part II
   Grace K. Dy et al, 2002, Journal of Clinical Oncology CrossRef